Abstract

The increased use of colistin against infections caused by Acinetobacter baumannii and Pseudomonas aeruginosa has resulted in colistin resistance. The purpose of this study was to detect plasmid-mediated mcr-1 gene in colistin-resistant A. baumannii and P. aeruginosa isolates. A total of 146 clinical isolates of A. baumannii (n = 62) and P. aeruginosa (n = 84) were collected from the four largest tertiary care hospitals in Peshawar, Pakistan. All bacterial isolates were phenotypically screened for multidrug resistance using the Kirby-Baur disc diffusion method. The minimum inhibitory concentration (MIC) of colistin in all isolates was phenotypically performed using dilution methods. mcr-1 gene was detected through polymerase chain reaction and the nucleotide sequence of amplicon was determined using Sanger sequencing. Approximately 96.7% A. baumannii and 83.3% P. aeruginosa isolates were resistant to multiple antibiotics. Colistin resistance was found in 9.6% (6/62) of A. baumannii and 11.9% (10/84) of P. aeruginosa isolates. Among 16 colistin resistant isolates, the mcr-1 gene was detected in one A. baumannii (1.61% of total isolates; 16.6% of colistin resistant isolates) and one P. aeruginosa strain (1.19% of total isolates; 10% of colistin resistant isolates). Nucleotide BLAST showed 98-99% sequence similarity to sequences of the mcr-1 gene in GenBank. Our study reports, for the first time, the emergence of plasmid-mediated mcr-1-encoded colistin resistance in multidrug resistant strains of A. baumannii and P. aeruginosa. Further large scales studies are recommended to investigate the prevalence of this mode of resistance in these highly pathogenic bacteria.

Highlights

  • The increased use of colistin against infections caused by Acinetobacter baumannii and Pseudomonas aeruginosa has resulted in colistin resistance

  • From 250 clinical specimens collected from four major hospitals in Peshawar, Pakistan in seven months, approximately 146 clinical isolates of A. baumannii (n = 62) and P. aeruginosa (n = 84) were obtained

  • 96.7% A. baumannii and 83.3% P. aeruginosa isolates were detected as multiple drug-resistant (MDR)

Read more

Summary

Introduction

The increased use of colistin against infections caused by Acinetobacter baumannii and Pseudomonas aeruginosa has resulted in colistin resistance. The purpose of this study was to detect plasmid-mediated mcr-1 gene in colistin-resistant A. baumannii and P. aeruginosa isolates. That cause hospital-related infections such as bacteremia, urinary tract infections, skin infections, soft tissue infections, and ventilator-associated infections at a variety of anatomical sites primarily in already ill and immune-deficient individuals[4,5,6,7] These critical pathogens are becoming resistant to almost all important classes of antibiotics such as carbapenems, aminoglycosides, beta-lactams, and fluroquinolones, leaving behind no appropriate treatment option[8]. This issue is extremely serious for clinicians to treat infections caused by MDR A. baumannii and P. aeruginosa Gram-negative bacteria. WHO has included colistin in the list of “last-resort antibiotics” to be used against these emerging superbugs[9]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call